You are here

MPX Bioceutical Corporation

MPX Logo
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
MPX
CSE Index: 
Currency: 


MPX Bioceutical Corporation (formerly known as The Canadian Bioceutical Corporation) is a multi-state diversified cannabis company with operations focused in the U.S. in the adult use and medical cannabis markets. The issuer’s foundation is built on its profitable operations in Arizona, with two Health 4 Life Dispensaries and well established Melting Point Extracts (MPX) Brand and GreenMart which holds cultivation and production licenses for both the medical and “adult use” sectors in Nevada and is already selling wholesale into the Nevada medical cannabis market. The business has also optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under the “Health for Life” brand. MPX is currently building-out facilities in Fall River, Massachusetts, which includes a 40,000 square foot property zoned and licensed for cannabis cultivation and a retail dispensary. MPX also manages and has options to purchase three dispensaries and one production facility in Maryland . MPX plans to replicate its success in Arizona to become a dominant multi-state operator.

You are here

MPX Bioceutical Corporation (MPX)

SEDAR Information

Company Info

Address
Yonge Norton Centre
5255 Yonge Street, Suite 701
Toronto, ON M2N 6P4
Canada
Phone
416-840-3725
Fax
877-595-1828
Email
info@mpxbioceutical.com
Website
http://www.mpxbioceutical.com
Listing date
Friday, January 27, 2017
Transfer Agent
Computershare Investor Services Inc.
Auditor
Deloitte LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
404,014,987
Reserved for Issuance: 
249,197,277

Company Officers

W. Scott Boyes, Chairman, President and Chief Executive Officer
Elizabeth M. Stavola, Chief Operating Officer
David McLaren, Chief Financial Officer

Bulletins

03/11/2017

2017-1104 – Name and Symbol Change - The Canadian Bioceutical Corporation (BCC)

November 3, 2017

The Canadian Bioceutical Corporation has announced a name change to MPX Bioceutical Corporation. Shares will begin trading under the new name and symbol on November 6, 2017.

Disclosure documents are available at www.thecse.com

Effective Date: November 6, 2017
New Symbol:  MPX
New CUSIP:  553443 10 2
New ISIN: CA 553443 10 2 1

Advertisement

Publicité

Latest CSE News

Upcoming Events

12_11_13th_MA_Forum_Website

Into the Future – Emerging Tech Conference

Friday, December 14, 2018 -
9:00am to 3:00pm
01_10_New_Year_Kick_Off_2019_Website

New Year Kickoff 2019

Thursday, January 10, 2019 -
6:00pm to 11:00pm
01_15_Benzinga_Cannabis_Capital_Conference_Website

Benzinga Cannabis Capital Conference

Tuesday, January 15, 2019 (All day) to Wednesday, January 16, 2019 (All day)